Noticias de ABUS_US

Noticias del mercado

Últimas noticias sobre ABUS_US — 77 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ABUS_US ✕ 77 resultados
26/04/2026 ABUS_US — MSN
Arbutus shares jump after FDA grants fast track status to hepatitis B therapy
24/04/2026 ABUS_US — MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving Average - Here's What Happened

Las acciones de Arbutus Biopharma (NASDAQ:ABUS) superan la media móvil de 200 días: ¿qué

23/04/2026 ABUS_US — MSN
Arbutus shares jump after FDA grants fast track status to hepatitis B therapy
23/04/2026 ABUS_US — Insider Monkey
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran
23/04/2026 ABUS_US — Yahoo Finance
Arbutus Biopharma (ABUS) Wins FDA Fast Track for Imdusiran
23/04/2026 ABUS_US — Xã Thanh Hà
ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates, shares rise nearly three percent on soaring year over year revenue. - Social Trade Signals
22/04/2026 ABUS_US — haiphong.gov.vn
ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates, shares rise nearly three percent on soaring year over year revenue. - Annual Summary
22/04/2026 ABUS_US — sonla.gov.vn
ABUS Arbutus Biopharma Corporation beats fourth quarter 2025 earnings estimates, shares rise nearly three percent on soaring year over year revenue. - Annual Summary
22/04/2026 ABUS_US — MyChesCo
Arbutus Drug Candidate Receives FDA Fast Track Designation
20/04/2026 ABUS_US — tayninh.gov.vn
Arbutus (ABUS) Stock: Stability Assessment (Momentum Fading) 2026-04-20 - Real-time Trade Ideas
18/04/2026 ABUS_US — vinhcong.tayninh.gov.vn
Arbutus (ABUS) Stock Upside Volume (+0.85%) 2026-04-18 - Community Sell Signals
18/04/2026 ABUS_US — ADVFN
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
18/04/2026 ABUS_US — newser.com
Arbutus (ABUS) Stock Upside Volume (+0.85%) 2026-04-18 - Short Setup
18/04/2026 ABUS_US — newser.com
Arbutus (ABUS) Stock Upside Volume (+0.85%) 2026-04-18 - Crowd Risk Alerts
17/04/2026 ABUS_US — Sahm
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
17/04/2026 ABUS_US — Yahoo Finance
Jefferies Sees Reduced Upside for Arbutus Biopharma Corporation (ABUS) on Higher Appeal Probability
17/04/2026 ABUS_US — DirectorsTalk Interviews
Arbutus Biopharma (ABUS) Stock Analysis: Unveiling an 11.5% Upside in the Biotech Sector
15/04/2026 ABUS_US — European AIDS Treatment Group
Hepatitis B: Updates from Aligos Therapeutics, Arbutus Biopharma Corporation and Precision BioSciences
15/04/2026 ABUS_US — MarketScreener
Arbutus Biopharma Says Imdusiran Receives FDA Fast Track Designation for Chronic Hepatitis B
15/04/2026 ABUS_US — Yahoo Finance ES ← EN
Arbutus recibe la designación de vía rápida de la FDA de EE. UU. para Imdusiran para el tratamiento de la hepatitis B crónica

Página 2 de 4

keyboard_arrow_up